Why the study?
What are the prognostic factors for local recurrence and metastatic disease in patients with primary synovial sarcoma treated by surgery?
What are the prognostic factors for local recurrence and metastatic disease in patients with primary synovial sarcoma treated by surgery?
Tumor size smaller than 4 cm and a mitotic rate lower than 15 per 10 high-power fields are associated with a favorable prognosis in patients with primary synovial sarcoma.
Answers are grounded in this paper and cite their sources.
Supports size- and mitotic rate-based risk stratification in synovial sarcoma; leaves open prospective validation before guiding therapy.
The authors analyzed the prognosis in a population-based series of 24 patients with primary synovial sarcoma in the extremities (22) and trunk wall (two), all of whom were principally treated by surgery. No patient had evidence of metastatic disease at the time of diagnosis of the primary tumor. After 3 to 19 years of follow-up, six patients had developed local recurrence and 12 had died of metastatic disease including those six with local recurrence. All patients with tumors smaller than 4 cm were alive without evidence of disease, as were also four of the five patients who had larger tumors, but with a mitotic rate lower than 15 per 10 high-power fields. The association between local recurrence and metastatic disease may be more statistical than causal, since patients with both these events had more often larger tumors with a high mitotic rate.
No takes yet. Share an insight, caveat, or question.
Rööser et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: